“When the FDA says ‘we think you ought to consider’ something, that should not
be viewed as a suggestion, but as a mandate,” he explains. “Companies are
foolish if they don’t follow what the FDA has suggested.” A biotech takes on
significant and unnecessary risk if it doesn’t follow an FDA suggestion or
proactively address the FDA’s concerns. …

While genetic engineering is common in the food industry, a number of biotechs
are also using the science to produce hormones and antibodies that can be used
therapeutically. …

Fortunately, AGBIOS, a Canadian company with vast experience in public safety
and risk assessment of biotechnology products, has taken upon itself to deliver
an online repository of knowledge about these important organisms. …
AƦČ章Ɛ䁈Ɛ